Skip to main content
. 2021 Mar 19;58(7):919–927. doi: 10.1007/s00592-021-01700-2

Table 1.

Flash Glucose Monitoring improves glycosylated hemoglobin

Total Device Control P-value (device vs control)
BMI kg/m2
T0 (mean ± SD) 28.3 ± 5.1 26.7 ± 4.7 30.5 ± 4.9 0.0038*
T1 (mean ± SD) 28.1 ± 5.5 26.1 ± 5.4 30.7 ± 4.6 0.0012*
BMI kg/m2 (T1-T0)
Mean ± SD − 0.1102 ± 1.586 − 0.3719 ± 1.750 0.2164 ± 1.383 0.1740
Mean ± SEM − 0.1102 ± 0.2065 − 0.3719 ± 0.3093 0.2164 ± 0.2766
HbA1c %
T0 (mean ± SD) 7.8 ± 1.5 8.0 ± 1.6 7.6 ± 1.3 0.2733
T1 (mean ± SD) 7.8 ± 1.8 7.6 ± 1.4 8.0 ± 2.2 0.3682
HbA1c % (T1-T0)
Mean ± SD − 0.1531 ± 2.332 − 0.5086 ± 1.785 0.4720 ± 1.928 0.0470*
Mean ± SEM − 0.1531 ± 0.2915 − 0.5086 ± 0.3018 0.4720 ± 0.3855

*indicate a P-value with a difference between the device and the control groups which is statistically significant